Clinical Trial Scams, Big Pharma
Denise Mouro, RN, research nurse at the University of Michigan Comprehensive Can...
Dr. Mark Mulligan, MD, executive director of the Hope Clinic of the Emory Vaccin...
Dr. Harry Keyserling, professor of pediatric infectious diseases at Emory School...
Dr. Mark Mulligan of the Emory Vaccine Center gives an overview of the H1N1 flu ...
UMHealthSystem |
(0) (0 Votes)
|
Views: (286) Date: (20-03-10) Time: (00:01:02) |
Description: Based on these research results, the University of Michigan Comprehensive Cancer Center will soon begin a new clinical study of a drug similar to rapamycin in adult patients with chronic myeloid leukemia, or CML. The study will be led by Moshe Talpaz, MD, the umcccs director of translational research.